KIPRUN Trial
Cross-source consensus on KIPRUN Trial from 1 sources and 6 claims.
1 sources · 6 claims
Comparisons
Background
Where it comes from
Other
Highlighted claims
- The trial is registered on ClinicalTrials.gov as NCT07211620. — KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients
- The trial compares procalcitonin kinetics-guided antibiotic initiation with absolute procalcitonin value-guided initiation. — KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients
- KIPRUN is a prospective, multicentre, randomized, controlled, parallel-group superiority trial in critically ill adults. — KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients
- KIPRUN is being conducted in adult ICUs in public hospitals and academic centres in Hungary. — KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients
- KIPRUN is planned to start on 1 December 2025 and run for 24 months. — KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients
- KIPRUN is presented as the first multicentre randomized controlled trial of PCT kinetics-guided antibiotic initiation in critically ill patients. — KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients